These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation. Hsieh MS, Wang H, Lee YH, Ko JY, Chang YL. Hum Pathol; 2017 Mar 25; 61():9-18. PubMed ID: 27769871 [Abstract] [Full Text] [Related]
26. Intracranial myxoid angiomatoid fibrous histiocytoma with "classic" histology and EWSR1:CREM fusion providing insight for reconciliation with intracranial myxoid mesenchymal tumors. Tan NJH, Pratiseyo PD, Wahjoepramono EJ, Kuick CH, Goh JY, Chang KTE, Tan CL. Neuropathology; 2021 Aug 25; 41(4):306-314. PubMed ID: 34254369 [Abstract] [Full Text] [Related]
27. EWSR1/FUS-CREB fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities. Argani P, Harvey I, Nielsen GP, Takano A, Suurmeijer AJH, Voltaggio L, Zhang L, Sung YS, Stenzinger A, Mechtersheimer G, Dickson BC, Antonescu CR. Mod Pathol; 2020 Nov 25; 33(11):2233-2243. PubMed ID: 32770123 [Abstract] [Full Text] [Related]
29. Systemic inflammation caused by an intracranial mesenchymal tumor with a EWSR1::CREM fusion presenting associated with IL-6/STAT3 signaling. Hojo K, Furuta T, Komaki S, Yoshikane Y, Kikuchi J, Nakamura H, Ide M, Shima S, Hiyoshi Y, Araki J, Tanaka S, Ozono S, Yoshida A, Nobusawa S, Morioka M, Nishikomori R. Neuropathology; 2023 Jun 25; 43(3):244-251. PubMed ID: 36328767 [Abstract] [Full Text] [Related]
30. A case of intracranial myxoid mesenchymal tumor with EWSR1:CREM fusion in an adult female: Extensive immunohistochemical evaluation. Kambe A, Kuwamoto S, Shimizu T, Amisaki H, Sakamoto M, Inagaki H, Kurosaki M. Neuropathology; 2021 Aug 25; 41(4):315-323. PubMed ID: 34258808 [Abstract] [Full Text] [Related]
32. Case report: The activity of multi-kinase VEGF inhibitor, Pazopanib, in metastatic undifferentiated round cell sarcomas harboring EWSR1::CREM fusion: clinicopathological series of two cases and literature review. Campoverde L, Camacho F, Alessandrino F, Evans MG, Elliot A, Rosenberg A, Trent J. Front Oncol; 2023 Aug 25; 13():1215003. PubMed ID: 37829338 [Abstract] [Full Text] [Related]
33. Elucidating the Diagnostic Complexity of Round Cell Sarcoma with EWSR1-CREM Fusion: A Comprehensive Case Study. Yen H, Chou JL, Li YF, Wang DS. Medicina (Kaunas); 2024 Mar 27; 60(4):. PubMed ID: 38674190 [Abstract] [Full Text] [Related]
34. Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion: A Clinicopathologic Study of 8 Cases. Shibayama T, Shimoi T, Mori T, Noguchi E, Honma Y, Hijioka S, Yoshida M, Ogawa C, Yonemori K, Yatabe Y, Yoshida A. Am J Surg Pathol; 2022 Jan 01; 46(1):134-146. PubMed ID: 34049318 [Abstract] [Full Text] [Related]
36. Expression of Transcription Factor CREM in Human Tissues. Kaprio H, Heuser VD, Orte K, Tukiainen M, Leivo I, Gardberg M. J Histochem Cytochem; 2021 Aug 01; 69(8):495-509. PubMed ID: 34261344 [Abstract] [Full Text] [Related]